Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
We aimed to detect interaction of PTPN2 with VDR, or with other vitamin D pathway genes (GC, CYP2R1, DHCR7, CYP24A1), in determining risk of JIA.
Source: Objectives. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Full studies
PReS-FINAL-2149: Interaction of PTPN2 and vitamin D GC sequence variants and risk of juvenile idiopathic arthritis
Study design awaiting verification · Pediatric Rheumatology Online Journal · 2013
Original publication title
PReS-FINAL-2149: Interaction of PTPN2 and vitamin D GC sequence variants and risk of juvenile idiopathic arthritis
Copyright © 2013 Ellis et al.; licensee BioMed Central Ltd.
Original publication · Publisher record · CC BY 2.0 · CC0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What objectives does the paper state?
We aimed to detect interaction of PTPN2 with VDR, or with other vitamin D pathway genes (GC, CYP2R1, DHCR7, CYP24A1), in determining risk of JIA.
Source: ObjectivesStudy methods
What methods does the paper describe?
15 snps were genotyped in 324 JIA cases and 568 controls from the childhood Arthritis Risk factor Identification study (CLARITY) in Melbourne Australia. We looked for association of each SNP with JIA in the entire dataset, and performed sensitivity analyses restricting to Caucasians (case n = 204, control n = 348) to control for population stratification. We then looked for interaction of PTPN2 with vitamin D genes in determining JIA risk on both a multiplicative and additive scale. Multiplicative interaction was assessed by the use of a product term in logistic regression.
Additive interaction was assessed by calculating the Relative Excess Risk due to Interaction (RERI), along with 95% confidence intervals and p value using bootstrapping and permutation procedures respectively.
Source: MethodsDisclosure of interest
None declared.
Source: Disclosure of interestResults
No snps were individually associated with JIA, except GC rs1155563 which was marginally associated in the entire dataset (p = 0.023), but not in Caucasians. A multiplicative interaction was observed between PTPN2 and VDR in the entire dataset (p = 0.016), but not in Caucasians. However, multiplicative interactions were observed between PTPN2 and GC which were evident overall and particularly among Caucasians (eg PTPN2 rs254151 and GC rs1155563: p = 0.0009). On an additive scale, possibly better reflecting biological interaction, we observed a RERI that deviated significantly from zero, providing further evidence of a negative interaction (PTPN2 rs254151 and GC rs1155563: RERI = -1.09; 95% CI -2.08, -0.38; p = 0.0004).
Source: ResultsConclusion
We have identified interaction between PTPN2 and GC in determining risk of JIA in Caucasian children recruited to CLARITY. The evidence of interaction also on an additive scale adds biological plausibility. The data is consistent with the notion that PTPN2 is responsive to vitamin D, since GC variants alter the delivery of vitamin D to target cells, and rs1155563 is associated with circulating vitamin D levels. While our findings await replication, they do support the concept that vitamin D may be an environmental factor that interacts with immune-related genes in JIA.
Source: ConclusionAuthors’ abstract
Read the full paper
Introduction
The causes of autoimmune diseases, including juvenile idiopathic arthritis (JIA) are presumed to involve the interplay of genes and environment. Vitamin D interacts with genes via vitamin D response elements (vdres). The gene PTPN2, associated with various autoimmune diseases including JIA, carries a VDRE and is regulated by vitamin D. Recently, an interaction between PTPN2 and VDR (vitamin D receptor gene) was reported for type 1 diabetes, such that disease association with VDR differed by PTPN2 genotype.
Objectives
We aimed to detect interaction of PTPN2 with VDR, or with other vitamin D pathway genes (GC, CYP2R1, DHCR7, CYP24A1), in determining risk of JIA.
Methods
15 snps were genotyped in 324 JIA cases and 568 controls from the childhood Arthritis Risk factor Identification study (CLARITY) in Melbourne Australia. We looked for association of each SNP with JIA in the entire dataset, and performed sensitivity analyses restricting to Caucasians (case n = 204, control n = 348) to control for population stratification. We then looked for interaction of PTPN2 with vitamin D genes in determining JIA risk on both a multiplicative and additive scale. Multiplicative interaction was assessed by the use of a product term in logistic regression.
Additive interaction was assessed by calculating the Relative Excess Risk due to Interaction (RERI), along with 95% confidence intervals and p value using bootstrapping and permutation procedures respectively.
Results
No snps were individually associated with JIA, except GC rs1155563 which was marginally associated in the entire dataset (p = 0.023), but not in Caucasians. A multiplicative interaction was observed between PTPN2 and VDR in the entire dataset (p = 0.016), but not in Caucasians. However, multiplicative interactions were observed between PTPN2 and GC which were evident overall and particularly among Caucasians (eg PTPN2 rs254151 and GC rs1155563: p = 0.0009). On an additive scale, possibly better reflecting biological interaction, we observed a RERI that deviated significantly from zero, providing further evidence of a negative interaction (PTPN2 rs254151 and GC rs1155563: RERI = -1.09; 95% CI -2.08, -0.38; p = 0.0004).
Conclusion
We have identified interaction between PTPN2 and GC in determining risk of JIA in Caucasian children recruited to CLARITY. The evidence of interaction also on an additive scale adds biological plausibility. The data is consistent with the notion that PTPN2 is responsive to vitamin D, since GC variants alter the delivery of vitamin D to target cells, and rs1155563 is associated with circulating vitamin D levels. While our findings await replication, they do support the concept that vitamin D may be an environmental factor that interacts with immune-related genes in JIA.
Disclosure of interest
None declared.
Publication and source details
Original title: PReS-FINAL-2149: Interaction of PTPN2 and vitamin D GC sequence variants and risk of juvenile idiopathic arthritis
JA Ellis; KJ Scurrah; RA Chavez; AL Ponsonby; A Pezic; RC Allen; JD Akikusa; JE Munro
Pediatric Rheumatology Online Journal · 2013
Copyright © 2013 Ellis et al.; licensee BioMed Central Ltd.2013Ellis et al.; licensee BioMed Central Ltd.https://creativecommons.org/licenses/by/2.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T19:46:41.115251+00:00
DOI: 10.1186/1546-0096-11-s2-p161 · PMC4044391